MedTrace Logo

The Clinical Utility of the Congo-Red Dot Test for Diagnosis and Early Prediction of Preeclampsia During Pregnancy

NCT02455544 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 346

Last updated 2018-10-09

No results posted yet for this study

Summary

The aim of the study is to validate in a prospective fashion the value of the Congo-Red Dot (CRD) test for diagnosis of preeclampsia. The working hypothesis is that in pregnancies complicated by preeclampsia, will display urine congophilia and have a positive CRD test.

Conditions

Sponsors & Collaborators

  • Catalin S Buhimschi, MD

    lead OTHER

Principal Investigators

  • Catalin S Buhimschi, MD · The Ohio State University Department of Obstetrics and Gynecology

  • Irina A Buhimschi, MD · Nationwide Children's Hospital, Center for Perinatal Research

Eligibility

Min Age
18 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2018-07-31
Completion
2018-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02455544 on ClinicalTrials.gov